Characterization of the African HIV-1 isolate CBL-4 (RUT) by partial sequence analysis and virus neutralization with peptide antibody and antisense phosphate-methylated DNA.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  AIDS (London)

• Publication date

  1990-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/00002030-199006000-00010PMID 2201319
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphate-methylated DNA aimed at HIV-1 RNA loops and integrated DNA inhibits viral infectivity.

  1990cited by this paper
• Rapid and simple method for purification of nucleic acids

  1990cited by this paper
• Antigenicity of linear B-cell epitopes in the C1, V1, and V3 region of HIV-1 gp 120.

  1989cited by this paper
• Regiospecific inhibition of DNA duplication by antisense phosphate-methylated oligodeoxynucleotides.

  1989cited by this paper
• HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions.

  1989cited by this paper
• Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations.

  1989cited by this paper
• Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.

  1988cited by this paper
• Human antibody response to a strain-specific HIV-1 gp120 epitope associated with cell fusion inhibition.

  1988cited by this paper
• Nucleotide Sequence Analysis of the env Gene of a New Zairian Isolate of HIV-1

  1988cited by this paper
• Baculovirus-expressed gp160 of HIV-1 induces antibodies with isolate-specific binding to a nine-amino acid sequence related to type-specific cell fusion inhibition.

  1988cited by this paper
• Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.

  1988cited by this paper
• Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.

  1988cited by this paper
• Dideoxy sequencing method using denatured plasmid templates.

  1986cited by this paper
• Variable and conserved neutralization antigens of human immunodeficiency virus

  1986cited by this paper

• Oridonin inhibits inflammation of epithelial cells via dual-targeting of CD31 Keap1 to ameliorate acute lung injury

  2023cites this paper
• Phosphate-Methylated Oligonucleotides Past, Present and Future

  2020cites this paper
• Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement

  2020cites this paper
• Ability of the V 3 Loop of Simian Immunodeficiency Virus To Serve as a Target for Antibody-Mediated Neutralization : Correlation of Neutralization Sensitivity , Growth in Macrophages , and Decreased Dependence on CD 4

  2001cites this paper
• Ability of the V3 Loop of Simian Immunodeficiency Virus To Serve as a Target for Antibody-Mediated Neutralization: Correlation of Neutralization Sensitivity, Growth in Macrophages, and Decreased Dependence on CD4

  2001cites this paper
• Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the gp41 C-terminal tail of human immunodeficiency virus type 1.

  2000cites this paper
• V3 sequence analysis and biological characterization of HTV‐1 isolates from asymptomatic and early symptomatic Tanzanian individuals

  2000cites this paper
• Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection.

  1999cites this paper
• Properties and mechanism of action of a 17 amino acid, V3 loop-specific microantibody that binds to and neutralizes human immunodeficiency virus type 1 virions.

  1999influential citation
• In vitro characterization of adult primary human immunodeficiency virus type 1: demonstration of distinctive single-cell killing phenotypes in spite of similar levels of viral replication.

  1997cites this paper
• In Vitro Characterization of HIV Type 1 Biological Clones from Asymptomatic and Symptomatic Pediatric Patients

  1996cites this paper
• [Progression of viral infection in twins born from a mother infected with human immunodeficiency virus].

  1995cites this paper
• [11 years since the discovery of the human immunodeficiency virus].

  1995cites this paper
• Biological Cloning of Functionally Diverse Quasispecies of HIV-1

  1993cites this paper
• Geographic diversity of human immunodeficiency virus type 1: serologic reactivity to env epitopes and relationship to neutralization.

  1992cites this paper
• Status of Ribozyme and Antisense‐Based Developmental Approaches for Anti‐HIV‐1 Therapy a

  1992cites this paper
• Induction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer element

  1991cites this paper
• Dextrin Sulphate and Fucoidan are Potent Inhibitors of HIV Infection in vitro

  1991cites this paper
• The V3 Loops of the HIV-1 and HTV-2 Surface Glycoproteins Contain Proteolytic Cleavage Sites: A Possible Function in Viral Fusion?

  1991cites this paper
• Variability among HIV and SIV strains of African origin.

  1991cites this paper
• Provenance of HIV strains

  1991cites this paper